AvaSpec in medical device to determine risk for cardiovascular diseases
The AGE Reader is a medical device to estimate cardiovascular risk. The AGE Reader non-invasively assesses the accumulation of advanced glycation endproducts (AGE’s) in the patient using autofluorescence of the skin with ultraviolet light. In the AGE Reader is an Avaspec spectrometer used to do this. AGE’s have a pivotal role in the development of chronic complications of diabetes and other common conditions. The amount of AGE in tissue serves as an important risk predictor of such complications.
The non-invasive measurement immediately offers valuable additional information, comfortably and safely for your patient and you. The AGE Reader has been validated in several large-scale, clinical trials over the past 6 years involving 1000s of adults.
Products